Influence of plasma processing on recovery and analysis of circulating nucleic acids.
Page K, Guttery DS, Zahra N, Primrose L, Elshaw SR, Pringle JH, Blighe K, Marchese SD, Hills A, Woodley L, Stebbing J, Coombes RC, Shaw JA
Purpose
Conclusion
Studies (2)
Purpose
The purpose of this study was to determine the effect of cfDNA extraction method and centrifugation speed on the yield of amplifiable DNA and deep sequencing results in plasma. The effect of DNA extraction method on cfDNA yield was determined using pooled plasma from 3 healthy donors. To determine the effect of extraction method on deep sequencing results, venous blood from 4 patients with metastatic breast cancer was drawn into EDTA tubes and centrifuged at 1000 x g for 10 min at 4 degrees C, and plasma was removed. Plasma was centrifuged at 1000 x g (or 2000 x g, or 10000 x g) for 10 min and stored at -80 degrees C.
Summary of Findings
There was no effect of the speed of the second centrifugation step on the CT of GAPDH. cfDNA yield, as determined by real-time PCR, was highest when cfDNA was extracted from the single plasma pool using the QIAamp DNA Blood Mini or CNA kits, with 1/10 as much cfDNA obtained using the NucleoSpin Plasma XS Kit or the FitAmp Plasma/Serum DNA Isolation kit. Recovery of a 23 kb fragment of spiked DNA was comparable between the two QIAamp kits, but recovery of a 564 bp fragment was highest using the QIAamp CNA kit. Overall, the number of deep sequencing reads for cfDNA isolated using the two QIAgen kits was very strongly correlated (r>0.95), but in one specimen, the correlation was strong (r=0.87) with more uniform coverage observed using cfDNA isolated with the QIAamp CNA kit. Of the 167 sequence variants identified, 136 were identified at a similar rate using cfDNA isolated with either kit, and 31 were identified using only one kit, and these generally were detected with fewer reads.
Biospecimens
FluidPlasmaFluidBloodPreservation Types
FrozenDiagnoses
NeoplasticCarcinomaNormalPlatforms
DNAReal-time qPCRDNANext generation sequencingPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Centrifugation Multiple speeds comparedAnalyte Extraction and Purification Analyte isolation method FitAmp Plasma/Serum DNA Isolation kitNucleoSpin Plasma XS KitQIAamp DNA Blood Mini kitQIAamp circulating nucleic acid kitsReal-time qPCR Specific Targeted nucleic acid Beta actinGAPDHHPRT1
Purpose
The purpose of this study was to determine the effects of delayed centrifugation of blood, centrifugation speed, extraction method, storage duration and array platform on miRNA yield and quantification in plasma. To determine the effects of extraction method, pooled purchased plasma and plasma specimens from 3 patients with primary or metastatic breast cancer were used. To investigate the effects of plasma processing, blood specimens were obtained from 5 healthy patients. To determine the effects of storage, two plasma pools consisting of 10 specimens each from patients with metastatic breast cancer were used. Venous blood was drawn into EDTA tubes, split into two specimens and centrifuged 2 h or 6 h later at 1000 x g for 10 min at 4 degrees C, and plasma was removed. Plasma was recentrifuged at different speeds (1000 x g, 2000 x g, or 10000 x g) and stored at -80 degrees C. After thawing, plasma was centrifuged at 1000 x g for 5 min at room temperature and placed in a new tube before DNA or miRNA extraction.
Summary of Findings
The authors report it was not possible to obtain sufficient miRNA to amplify miR-21 or miR-191 from 1 mL of purchased pooled plasma. When plasma was pooled from 3 patients with primary breast cancer, significantly more miRNA was obtained using the QIAamp CNA or miRNeasy Plasma/Serum kit than the miRvana microRNA Isolation kit (p <0.001). The cycle threshold values for miR-21 and miR-191 were lower when miRNA was isolated using the miRNeasy Serum/Plasma kit than the QIAamp CNA and miRvana kits. However, the miRNA profile, as determined by low density array was comparable between different extraction methods, and the miRNeasy Serum/Plasma kit was chosen for the remaining work. miRNA yield was not affected by the volume of plasma used or delayed centrifugation, but levels of miR-15b (p<0.001), miR-16 (p<0.05), miR-21 (p<0.01), miR-24 (p<0.01) and miR-484 (p<0.05) were significantly reduced, and levels of miR-191 (p<0.001) were increased when centrifugation was delayed. When the second centrifugation speed was increased from 1000 x g to 2000 x g, the number of miRNAs detected decreased from 195 to 187, and when the speed was further increased to 10,000 x g, only 138 miRNAs were detected. While the relative CT values of most miRNAs were unaffected by the centrifugation speed, the platelet associated miRNAs were selectively reduced by faster centrifugation. While a very strong correlation in miRNA levels was observed for replicate specimens using both low density array platforms (r=0.95), there was only a modest correlation between miRNA levels in the two platforms (r=0.60). Further, non-specific amplification, as determined by melting curve analysis, was observed for the low abundance miRNAs using the Exiqon miRCURY LNA miRNA PCR array. Pooled plasma stored for >12 years at -80 degrees C only allowed for detection of 177 miRNAs, but 202 were detected in freshly frozen plasma. However, the CT values were comparable between stored and unstored plasma.
Biospecimens
FluidPlasmaFluidBloodPreservation Types
FrozenDiagnoses
NeoplasticCarcinomaNormalPlatforms
RNAAutomated electrophoresis/BioanalyzerRNALow density arrayRNAReal-time qRT-PCRPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Aliquot size/volume 1 mL200 uL500 uLBiospecimen Aliquots and Components Centrifugation Centrifugation delays investigatedMultiple speeds comparedStorage Storage duration 0 years>12 yearsStorage Time at room temperature 2 h6 hAnalyte Extraction and Purification Analyte isolation method QIAamp Circulating Nucleic Acid kitmiRNeasy Serum/Plasma KitmiRvana microRNA Isolation kitReal-time qRT-PCR Specific Targeted nucleic acid miR-191miR-21Low density array Specific Type of array Exiqon miRCURY LNA microRNA PCR arrayTLDA